Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;77(2):195-9.
doi: 10.1111/j.1365-2265.2012.04366.x.

Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours

Anya Rothenbuhler  1 , Anelia Horvath, Rossella Libé, Fabio R Faucz, Amato Fratticci, Marie L Raffin Sanson, Delphine Vezzosi, Monalisa Azevedo, Isaak Levy, Madson Q Almeida, Maya Lodish, Maria Nesterova, Jérôme Bertherat, Constantine A Stratakis
Affiliations

Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours

Anya Rothenbuhler et al. Clin Endocrinol (Oxf). 2012 Aug.

Erratum in

  • Clin Endocrinol (Oxf). 2012 Dec;77(6):943

Abstract

Background: Genetic aberrations in various components of cAMP signalling pathway predispose to endocrine tumours. Mutations in the phosphodiesterases (PDEs) are involved in the predisposition to adrenocortical neoplastic conditions.

Objective: To screen for genetic variations in PDE8B among patients with different types of adrenocortical tumours.

Design and subjects: This is a case-control study followed by functional analyses. Two hundred and sixteen unrelated patients with different types of adrenocortical tumours and 192 healthy control individuals participated in the study.

Methods: Bidirectional Sanger sequencing, in vitro cell line transfection and in silico modelling are used in this study.

Results: Nine different PDE8B sequence changes, six novel and three previously reported, were identified in our patients and controls. Two of the variations, seen only in the patient group, showed significant potential to impair protein function, both in vitro and in silico.

Conclusion: PDE8B is another PDE gene in which variations may contribute to predisposition of adrenocortical tumours.

PubMed Disclaimer

Conflict of interest statement

Disclosure summary: authors have no potential conflicts of interest

Figures

Figure 1
Figure 1
PDE (A) and cAMP (B) activity after transfection of HEK293 cells with WT and mutant PDE8B expression vectors.
See this image and copyright information in PMC

References

    1. Horvath A, Mericq V, Stratakis CA. Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. New England Journal of Medicine. 2008;358:750–752. - PubMed
    1. Horvath A, Giatzakis C, Tsang K, et al. A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. European Journal of Human Genetics. 2008;16:1245–1253. - PMC - PubMed
    1. Tsai LC, Shimizu-Albergine M, Beavo JA. The high affinity cAMP-specific phosphodiesterase 8B (PDE8B) controls steroidogenesis in the mouse adrenal gland. Molecular Pharmacology. 2010;79:639–648. - PMC - PubMed
    1. Horvath A, Boikos S, Giatzakis C, et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nature Genetics. 2006;38:794–800. - PubMed
    1. Horvath A, Giatzakis C, Robinson-White A, et al. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Research. 2006;66:11571–11575. - PubMed

Publication types

MeSH terms

Substances